NCT06795789

Brief Summary

The purpose of this trial is to learn how a multivitamin combined blueberry polyphenol supplement (Vitals+) influences cognitive function in healthy adults. A secondary aim is to see how the biochemical level of nutritional factors change with the supplement. This study will be completed fully remote (from the participants home without in-person visits). Participants will be asked to compete three steps over the course of 3 months: Step 1: Participants will be asked to complete an online cognitive function game (45 minutes) Step 2: Participants will receive a fingertip blood sample kit in the post to measure nutritional markers in the body (requiring 8 drops of blood). They will then be asked to complete the same online cognitive function game and answer some questions about their general health (50 minutes). After this, participants will be requested to start their multivitamin (Vitals+) subscription, once a day for 3 months. Step 3: This final step is the same as step 2. After 3 months participants will receive another fingertip blood sample kit in the post (requiring 8 drops of blood) and asked to complete the cognitive function games again (50 minutes). This will mark the end of the study. How these measurements responded to the multivitamin supplement will then be measured.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 9, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 28, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 28, 2025

Status Verified

January 1, 2025

Enrollment Period

7 months

First QC Date

January 9, 2025

Last Update Submit

January 27, 2025

Conditions

Healthy AdultCognitive Measures

Keywords

MultivitaminPolyphenolsBlueberryCognitive FunctionHomocysteineB-vitaminsVitamin D

Outcome Measures

Primary Outcomes (1)

  • Cognitive Function

    A validated online Cognitive Function test will be used to assess cognition pre-post intervention

    3 months

Secondary Outcomes (2)

  • Total homocysteine

    3 months

  • Vitamin D

    3 months

Study Arms (1)

Vitals+ (combined multivitamin and polyphenol supplement)

EXPERIMENTAL

Participants to supplement with Vitals+ multivitamin combined polyphenol supplement for 3 months

Dietary Supplement: Vitals+ (combined multivitamin and polyphenol supplement)

Interventions

Vitals+ (combined multivitamin and polyphenol supplement)DIETARY_SUPPLEMENT

Multivitamin with 19 essential nutrients combined with Bilberry polyphenols

Also known as: Vitals+
Vitals+ (combined multivitamin and polyphenol supplement)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy Men and Women age \>18 years
  • Newly subscribed to the nutritional supplement
  • Access to a PC or laptop with internet connection

You may not qualify if:

  • Unable to give informed consent
  • Consumed a nutritional supplement in past 3 months
  • Consuming \> 4 portions of B-vitamin fortified foods a week
  • Pregnant or breastfeeding
  • Diagnosis of a neurological condition, such as Dementia, depression or anxiety
  • Prescribed vitamin B12 injections

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Heights Research and Development

London, W1D 2LG, United Kingdom

Location

Heights Research and Development

London, W1D 2LG, United Kingdom

Location

Study Officials

  • Harry R Jarrett, Ph.D

    Heights

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Harry R Jarrett, Ph.D

CONTACT

020 3540 0354harry@yourheights.com

Lisa Holton, MSc

CONTACT

020 3540 0354lisa@yourheights.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2025

First Posted

January 28, 2025

Study Start

March 1, 2025

Primary Completion

October 1, 2025

Study Completion

December 1, 2025

Last Updated

January 28, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations

GB(2)